Cargando…

Uridine Diphosphate Promotes Rheumatoid Arthritis Through P2Y6 Activation

BACKGROUND: Uridine diphosphate (UDP) is an extracellular nucleotide signaling molecule implicated in diverse biological processes via specific activation of pyrimidinergic receptor P2Y, G Protein-Coupled, 6 (P2Y6). There is very little knowledge about the function and mechanism of UDP in rheumatoid...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hongxing, Wu, Hui, Fang, Kehua, Chang, Xiaotian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089376/
https://www.ncbi.nlm.nih.gov/pubmed/33953685
http://dx.doi.org/10.3389/fphar.2021.658511
_version_ 1783687033605062656
author Wang, Hongxing
Wu, Hui
Fang, Kehua
Chang, Xiaotian
author_facet Wang, Hongxing
Wu, Hui
Fang, Kehua
Chang, Xiaotian
author_sort Wang, Hongxing
collection PubMed
description BACKGROUND: Uridine diphosphate (UDP) is an extracellular nucleotide signaling molecule implicated in diverse biological processes via specific activation of pyrimidinergic receptor P2Y, G Protein-Coupled, 6 (P2Y6). There is very little knowledge about the function and mechanism of UDP in rheumatoid arthritis (RA). METHODS: This study used a quasi-targeted liquid chromatography-mass spectrometry (LC-MS) approach to investigate the unique expression of metabolites in RA synovial fluids (SF) (n = 10) with samples from osteoarthritis (OA) as controls (n = 10). RA fibroblast-like synoviocytes (FLSs) were collected from synovial tissues (n = 5) and cultured with UDP or MRS2578, a P2Y6 antagonist, and FLSs from OA were used as controls (n = 5). Rats with collagen-induced arthritis (CIA) were injected with UDP, MRS2578 or both (n = 9 for each group). P2Y6 expression was examined using real-time PCR, Western blotting and immunohistochemistry. Cell proliferation, apoptosis and migration of RA FLSs were measured using CCK-8 assay, real-time cell analysis, flow cytometry, wound healing assay and Transwell assay, respectively. The UDP levels in the culture medium, synovial fluid (n = 36) and peripheral blood (n = 36) of RA and CIA rats were measured using a Transcreener UDP Assay. Levels of proinflammatory cytokines were measured using a flow assay. Interleukin-6 (IL-6) levels were measured using ELISA and flow. RESULTS: LC-MS analysis detected significantly increased UDP levels in RA SF compared with OA SF, and the level was positively correlated with anticyclic citrullinated peptide (anti-CCP) and rheumatoid factor (RF)levels in RA. The increased UDP concentration was verified in the blood and synovial fluids of RA patients compared with samples from OA patients and healthy volunteers, respectively. UDP stimulated cell proliferation, migration and IL-6 secretion in RA FLSs and inhibited their apoptosis in culture, and MRS2578 inhibited these effects of UDP. UDP injection accelerated CIA and stimulated IL-6 production rather than other proinflammatory cytokines in the rat model, but simultaneous injection of MRS2578 suppressed these effects and alleviated CIA. P2Y6 expression was increased in RA and CIA synovial tissues. CONCLUSION: These results suggest that UDP is highly expressed in RA and stimulates RA pathogenesis by promoting P2Y6 activities to increase IL-6 production.
format Online
Article
Text
id pubmed-8089376
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80893762021-05-04 Uridine Diphosphate Promotes Rheumatoid Arthritis Through P2Y6 Activation Wang, Hongxing Wu, Hui Fang, Kehua Chang, Xiaotian Front Pharmacol Pharmacology BACKGROUND: Uridine diphosphate (UDP) is an extracellular nucleotide signaling molecule implicated in diverse biological processes via specific activation of pyrimidinergic receptor P2Y, G Protein-Coupled, 6 (P2Y6). There is very little knowledge about the function and mechanism of UDP in rheumatoid arthritis (RA). METHODS: This study used a quasi-targeted liquid chromatography-mass spectrometry (LC-MS) approach to investigate the unique expression of metabolites in RA synovial fluids (SF) (n = 10) with samples from osteoarthritis (OA) as controls (n = 10). RA fibroblast-like synoviocytes (FLSs) were collected from synovial tissues (n = 5) and cultured with UDP or MRS2578, a P2Y6 antagonist, and FLSs from OA were used as controls (n = 5). Rats with collagen-induced arthritis (CIA) were injected with UDP, MRS2578 or both (n = 9 for each group). P2Y6 expression was examined using real-time PCR, Western blotting and immunohistochemistry. Cell proliferation, apoptosis and migration of RA FLSs were measured using CCK-8 assay, real-time cell analysis, flow cytometry, wound healing assay and Transwell assay, respectively. The UDP levels in the culture medium, synovial fluid (n = 36) and peripheral blood (n = 36) of RA and CIA rats were measured using a Transcreener UDP Assay. Levels of proinflammatory cytokines were measured using a flow assay. Interleukin-6 (IL-6) levels were measured using ELISA and flow. RESULTS: LC-MS analysis detected significantly increased UDP levels in RA SF compared with OA SF, and the level was positively correlated with anticyclic citrullinated peptide (anti-CCP) and rheumatoid factor (RF)levels in RA. The increased UDP concentration was verified in the blood and synovial fluids of RA patients compared with samples from OA patients and healthy volunteers, respectively. UDP stimulated cell proliferation, migration and IL-6 secretion in RA FLSs and inhibited their apoptosis in culture, and MRS2578 inhibited these effects of UDP. UDP injection accelerated CIA and stimulated IL-6 production rather than other proinflammatory cytokines in the rat model, but simultaneous injection of MRS2578 suppressed these effects and alleviated CIA. P2Y6 expression was increased in RA and CIA synovial tissues. CONCLUSION: These results suggest that UDP is highly expressed in RA and stimulates RA pathogenesis by promoting P2Y6 activities to increase IL-6 production. Frontiers Media S.A. 2021-04-19 /pmc/articles/PMC8089376/ /pubmed/33953685 http://dx.doi.org/10.3389/fphar.2021.658511 Text en Copyright © 2021 Wang, Wu, Fang and Chang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wang, Hongxing
Wu, Hui
Fang, Kehua
Chang, Xiaotian
Uridine Diphosphate Promotes Rheumatoid Arthritis Through P2Y6 Activation
title Uridine Diphosphate Promotes Rheumatoid Arthritis Through P2Y6 Activation
title_full Uridine Diphosphate Promotes Rheumatoid Arthritis Through P2Y6 Activation
title_fullStr Uridine Diphosphate Promotes Rheumatoid Arthritis Through P2Y6 Activation
title_full_unstemmed Uridine Diphosphate Promotes Rheumatoid Arthritis Through P2Y6 Activation
title_short Uridine Diphosphate Promotes Rheumatoid Arthritis Through P2Y6 Activation
title_sort uridine diphosphate promotes rheumatoid arthritis through p2y6 activation
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089376/
https://www.ncbi.nlm.nih.gov/pubmed/33953685
http://dx.doi.org/10.3389/fphar.2021.658511
work_keys_str_mv AT wanghongxing uridinediphosphatepromotesrheumatoidarthritisthroughp2y6activation
AT wuhui uridinediphosphatepromotesrheumatoidarthritisthroughp2y6activation
AT fangkehua uridinediphosphatepromotesrheumatoidarthritisthroughp2y6activation
AT changxiaotian uridinediphosphatepromotesrheumatoidarthritisthroughp2y6activation